USE OF MIRNA-485 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
The present disclosure includes the use of a miRNA inhibitor for treating amyotrophic lateral sclerosis (ALS) associated with a decreased level of SIRT1 protein or SIRT1 gene expression, PGC-1α protein and/or PGC-1α gene expression, CD36 protein and/or CD36 gene expression, NRG1 protein and/or NRG...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
31.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure includes the use of a miRNA inhibitor for treating amyotrophic lateral sclerosis (ALS) associated with a decreased level of SIRT1 protein or SIRT1 gene expression, PGC-1α protein and/or PGC-1α gene expression, CD36 protein and/or CD36 gene expression, NRG1 protein and/or NRG1 gene expression, STMN2 protein and/or STMN2 gene expression, and/or NRXN1 protein and/or NRXN1 gene expression.
La presente descripción incluye el uso de un inhibidor de miARN para el tratamiento de la esclerosis lateral amiotrófica (ELA) asociada con un nivel disminuido de expresión de proteína SIRT1 o del gen SIRT1, expresión de proteína PGC-1a y/o del gen PGC-1a, expresión de proteína CD36 y/o del gen CD36, expresión de proteína NRG1 y/o del gen NRG1, expresión de proteína STMN2 y/o del gen STMN2 y/o expresión de proteína NRXN1 y/o del gen NRXN1. |
---|---|
AbstractList | The present disclosure includes the use of a miRNA inhibitor for treating amyotrophic lateral sclerosis (ALS) associated with a decreased level of SIRT1 protein or SIRT1 gene expression, PGC-1α protein and/or PGC-1α gene expression, CD36 protein and/or CD36 gene expression, NRG1 protein and/or NRG1 gene expression, STMN2 protein and/or STMN2 gene expression, and/or NRXN1 protein and/or NRXN1 gene expression.
La presente descripción incluye el uso de un inhibidor de miARN para el tratamiento de la esclerosis lateral amiotrófica (ELA) asociada con un nivel disminuido de expresión de proteína SIRT1 o del gen SIRT1, expresión de proteína PGC-1a y/o del gen PGC-1a, expresión de proteína CD36 y/o del gen CD36, expresión de proteína NRG1 y/o del gen NRG1, expresión de proteína STMN2 y/o del gen STMN2 y/o expresión de proteína NRXN1 y/o del gen NRXN1. |
Author | KOH Han Seok RYU Jin-hyeob MIN Hyun Su LIM Yu Na KIM Dae Hoon |
Author_xml | – fullname: KIM Dae Hoon – fullname: RYU Jin-hyeob – fullname: LIM Yu Na – fullname: MIN Hyun Su – fullname: KOH Han Seok |
BookMark | eNqNyr0KwjAQAOAMOvj3DoeTDoVaW9DxDIk5SJtyiaBTKRInSQv1_XHxAZy-5VuKWRpSXAh78wqchpq4waw8VUCNoQsFxx60YwisMFBzBawfLrBrDUmwGBSjBS-tYufJww6t36_F_NW_p7j5uRJbrYI0WRyHLk5j_4wpfrr6XuRFkefnsjrg8a_0BRCsL9A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | S DE MICRO ÁCIDO RIBONUCLEICO 485 (MIARN 485) PARA TRATAMIENTO DE ESCLEROSIS LATERAL AMIOTRÓFICA (ELA). |
ExternalDocumentID | MX2022009451A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2022009451A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:07:53 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2022009451A3 |
Notes | Application Number: MX20220009451 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221031&DB=EPODOC&CC=MX&NR=2022009451A |
ParticipantIDs | epo_espacenet_MX2022009451A |
PublicationCentury | 2000 |
PublicationDate | 20221031 |
PublicationDateYYYYMMDD | 2022-10-31 |
PublicationDate_xml | – month: 10 year: 2022 text: 20221031 day: 31 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | BIORCHESTRA CO., LTD |
RelatedCompanies_xml | – name: BIORCHESTRA CO., LTD |
Score | 3.2775931 |
Snippet | The present disclosure includes the use of a miRNA inhibitor for treating amyotrophic lateral sclerosis (ALS) associated with a decreased level of SIRT1... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | USE OF MIRNA-485 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221031&DB=EPODOC&locale=&CC=MX&NR=2022009451A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOJYgUfSiuXdrVhyFdP2xkbUabSX0a7cxAhG24iv--Sdx0T3tLcnAkB3eXS-5-B3DTNseqA6xuWtzScdFy9NJ-M_ROG5cTbmOnhWWBc5zY0RA_51Zeg49VLYzCCf1W4IhCo8ZC3ytlr-f_j1i-yq1c3JfvYmn2GLKury2jY9OUXQs0v9cNBtSnnuZ53TjXklTRZBadZbhbsC3v0RJoP3jpybKU-bpPCQ9gZyDYTatDqPFFA_a8Veu1BuzGyx9vMVwq3-II-sMsQDREMUkTV8eOhUgSkR5hNM2QCOYQSwOXkeQJufErZSkdRMRDfZfJ3DQkITdSmpEM3br97O4YrsOAeZEutjX6E8IozteO0D6B-nQ25aeA8ORhYheWuIdwEeV2eCEcsDHmuMCGI_G1zqC5gdH5RmoT9uXs11RfQL36_OKXwgdX5ZWS3Q8WqIIc |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0Gk6ENx7dKuPgzp-mGjTTvaKPVptDMDEbbhKv77JnXTPe0t5OBIDu4rufsdwFVHH1UTYFXd4IaK87alFuabpnY7uBhzE1ttLBucaWQGz_gxM7IafCx7YSqc0O8KHFFo1Ejoe1nZ69n_I5Zb1VbOb4t3sTW991nPVRbZsa7LqQWK2-95g9iNHcVxejRToqSiySo6Q7M3YLMr4Xll7PTSl20ps1Wf4u_C1kCwm5R7UOPzJjSc5ei1JmzTxY-3WC6Ub74P4XPqodhHlCSRrWLLQCQKSJ-wOEmRSOYQSzybkegB2fQ1Zkk8CIiDQpvJ2jQkITeSOCUpurbD9OYALn2POYEqjjX8E8KQZitX6BxCfTKd8CNAeHw3NnNDxCFcZLldngsHrI04zrFmSXytY2itYXSylnoBjYDRcBiS6KkFO5Lya7ZPoV5-fvEz4Y_L4ryS4w9VV4UJ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+MIRNA-485+INHIBITORS+FOR+TREATING+AMYOTROPHIC+LATERAL+SCLEROSIS+%28ALS%29&rft.inventor=KIM+Dae+Hoon&rft.inventor=RYU+Jin-hyeob&rft.inventor=LIM+Yu+Na&rft.inventor=MIN+Hyun+Su&rft.inventor=KOH+Han+Seok&rft.date=2022-10-31&rft.externalDBID=A&rft.externalDocID=MX2022009451A |